XEIA Venture Partners
Venture capitalActively deployingSan Francisco Β· 2 people tracked
Investment thesis
XEIA Venture Partners pursues cross-disciplinary exploration, investment and acceleration, organized around a 'Human 3' theme concerning the future of health, wellbeing and performance. The firm backs early-stage startups and is notably open to founding teams that are romantic couples, having found several such teams among its highest-performing portfolio companies in its first fund. It invested in roughly 11 companies across 2024 and the first half of 2025 and has raised a first fund plus a first close on a second fund.
Source: firm website, verified Aug 3, 2026.
Team Β· 2 people
from the firm's website
.jpeg)
What they invest in
from 3 of 22 portfolio companiesAI & Machine Learning Γ2Medical Devices Γ2Biotech Γ1Deep Tech Γ1Healthtech Γ1Longevity Γ1Wellness & Fitness Γ1
HQs:United StatesΓ1
Investments Β· 22 tracked
founders shown can be your intro pathVonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
JosΓ© Morales(Dr.)
Co-investorsSmartGateVC
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)Elise Jenkins(Co-founder & CTO)
Co-investorsArtesianBlackbird VenturesPossible VenturesSmartGateVCDivergent CapitalTopology Ventures
The page references health, wellbeing and performance under the banner "Human 3," alongside expertise in AI/ML, medicinal chemistry/pharmacology, and aging-brain research.
AI & Machine LearningLongevityWellness & Fitness
Portfolio news
latest coverage across their companiesCoherence Neuro Β· massdevice.com Β· Jun 25, 2026
Frequently asked questions
- How many investments has XEIA Venture Partners made?
- XEIA Venture Partners has 22 tracked investments, including 1 dated in the last 24 months.
- What sectors does XEIA Venture Partners focus on?
- XEIA Venture Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Longevity, Wellness & Fitness.
- Where is XEIA Venture Partners located?
- XEIA Venture Partners is headquartered in San Francisco, US.
- Who does XEIA Venture Partners co-invest with?
- XEIA Venture Partners most often shares deals with SmartGateVC, Blackbird Ventures, Possible Ventures, among 3 tracked co-investors.
Images
Co-investors Β· 2
Four Acres is an early-stage venture capital fund founded by native New Yorkers, focused on software-first technology companies.
Investment firm focused on emerging public and private companies in agriculture, consumer, healthcare, and technology sectors, leveraging deep expertise in small-cap markets.
Firms observed investing alongside XEIA Venture Partners, from public investor directories. Shared companies are the overlap with XEIA Venture Partners's recorded portfolio.
Similar investors
Lauder Partners, LLC is a technology-focused investment entity that invests both directly in companies and in funds (venture and other), primarily deploying the capital of Gary Lauder and his family.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Anthropy Partners is an investment firm backing founders building technologies that extend the capabilities of the human body and mind, focused on what it calls the 'long-human era'.
Embryo Ventures is an early-stage venture firm backing founders building technologies across human health and human experience, from clinical and consumer health to essential life infrastructure.
Proton Enterprises is a venture development firm that partners with leaders by combining capital, time, and talent to build mission-driven businesses, while also investing broadly and backing emerging fund managers.